Sunesis to Present at Upcoming Investor Conferences
September 01 2011 - 7:00AM
Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that
Daniel Swisher, Chief Executive Officer of Sunesis, will present at
two upcoming conferences:
- Stifel Nicolaus 2011 Healthcare Conference Friday, September
9th at 9:45 AM Eastern Time Four Seasons Hotel, Boston
- Rodman & Renshaw 13th Annual Healthcare Conference Tuesday,
September 13th at 12:05 PM Eastern Time Waldorf=Astoria, New York
City
A live webcast of the presentations will be available on the
Sunesis website at http://ir.sunesis.com. A replay of the webcasts
will be archived on the "Calendar of Events" page in the Investors
and Media section of the Sunesis website for two weeks following
the presentation.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the
development and commercialization of new oncology therapeutics for
the treatment of solid and hematologic cancers. Sunesis has built a
highly experienced cancer drug development organization committed
to advancing its lead product candidate, vosaroxin, in multiple
indications to improve the lives of people with cancer. For
additional information on Sunesis, please visit
www.sunesis.com.
The Sunesis Pharmaceuticals, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=8773
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals,
Inc.
CONTACT: Investor and Media Inquiries:
David Pitts
Argot Partners
212-600-1902
Eric Bjerkholt
Sunesis Pharmaceuticals Inc.
650-266-3717
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Oct 2023 to Oct 2024